Developing novel genetic counseling and testing approaches

As genetic testing becomes more common, the challenge is to identify strategies to make it accessible to everyone who needs it, and to make testing as efficient as possible. Traditional clinical genetics cancer care delivery models involve in-depth, in-person pre-test genetic education and counseling, followed by testing, and then in-person returning of results along with in-depth post-test genetic counseling. This model, however, may not be feasible for all situations, especially considering the rapid growth of testing approaches and a limited genetic provider workforce. Our projects aim to evaluate the psychological and behavioral implications of novel strategies to inform and support individuals as they consider and learn their genetic risk information. This work will help to maximize the potential benefits and minimize the potential harms of the increasing availability of genetic testing.

Some example projects are:

Improving Access to Genetic Information for Everyone (IMAGINE) Study

Dr. Hamilton is currently leading a large project to refine and evaluate a novel linguistically and culturally appropriate mainstreaming model of hereditary cancer multigene panel testing among patients receiving care at community hospitals in New York City. This work aims to promote effective risk communication, decision making, and more equitable delivery of genomic medicine to those at risk of hereditary cancer syndromes.

  • Sheikh R, Strang A, Chicaiza AM, Barthelus E, Oliveros S, Pagan-Lopez I, Lynch KA, Diamond L, Gonzalez CJ, Offit K, Robson ME, Stadler ZK, Hay JL, Hamilton JG. (2024, September). Tailoring pre- and post-test genetic educational resources for cancer patients varying in race/ethnicity, language, and education. Paper presented at the annual National Society of Genetic Counselors meeting, New Orleans, LA.
  • Christian-Afflu SN, Sheikh R, Strang A, Chicaiza AM, Oliveros S, Barthelus E, Pagan-Lopez I, Lynch KA, Diamond LC, Gonzalez CJ, Offit K, Robson ME, Liu YL, Gonsky JP, Bulone L, Stadler ZK, Hay JL, Hamilton JG. Adapting mainstreaming genetic education and clinical communication materials for cancer patients of varying backgrounds. Patient Educ Couns. 2026 Jan 16;146:109489. doi: 10.1016/j.pec.2026.109489. Epub ahead of print. PMID: 41643404.
  • Christian-Afflu SN, Chicaiza AM, Barthelus E, Oliveros S, Sheikh R, Strang A, Schofield E, Nouvini R, Alberty-Oller JJ, Winer AG, Gonsky JP, Bulone L, Liu YL, Offit K, Robson ME, Hay JL, Stadler ZK, Hamilton JG (2026, April). Variation in genetic literacy by cancer diagnosis, education, health literacy, and language among a diverse cohort of cancer patients in New York City. Poster presented at the Society of Behavioral Medicine annual meeting, Chicago, IL.

Responses to Genetic Risk Modifier Testing Among People with Hereditary Cancer Risks

Dr. Hamilton and her collaborators are conducting a series of studies regarding people’s interest and experiences with a novel SNP-based form of genetic testing. Among people with pathogenic variants in cancer predisposition genes such as BRCA1, BRCA2, ATM, CHEK2, and PALB2, this SNP-based “genetic modifier” testing can provide a polygenic risk score (PRS) and more precise information about their future cancer risks. Ongoing studies are aiming to determine the utility of PRS-informed personalized cancer risk estimates for cancer prevention decisions among patients with hereditary cancer risks.